Gül Yurtsever Süreyya, Biçmen Can, Gündüz Ayriz T, Ozkütük Nuri, Salman Serkan, Demirci Mustafa
İzmir Atatürk Training and Research Hospital, İzmir, Turkey.
Mikrobiyol Bul. 2011 Oct;45(4):623-31.
This study was conducted to compare BACTEC 460 TB system and the proportion method in commercially available and ready to use antibiotic added Löweinstein-Jensen (LJ) medium for susceptibility testing of first line drugs in Mycobacterium tuberculosis complex isolates. A total 238 M.tuberculosis strains isolated from clinical samples in our laboratory between 2006-2010 period were included in the study. Susceptibility testing for streptomycin, isoniazid, rifampicin and ethambutol in commercially provided LJ medium (Salubris Inc., Istanbul) was performed by the proportion method as recommended by the manufacturer, and the results were compared with the results of BACTEC 460 TB (Becton Dickinson, USA) system. Resistance rates of M.tuberculosis strains against streptomycin, isoniasid, rifampicin and ethambutol obtained by BACTEC 460 TB system were 19.7%, 42%, 40.8% and 18%, respectively. Those rates were 22.7%, 38.7%, 37% and 15.5%, respectively, by antibiotic added LJ proportion method. There was no statistically significant difference between the two methods in terms of resistance rates (p> 0.05). The rates of consistency between proportion method in LJ medium and BACTEC 460 TB system for streptomycin, isoniasid, rifampicin and ethambutol susceptibility were found as 85.3%, 92.4%, 95.4% and 92.4%, respectively. When comparing the reporting time (interval between beginning of the process to reporting of the results) of the methods, minimal, maximal and average reporting spans for BACTEC 460 TB system were 5, 12 and 8.08 ± 2.65 days, and 15, 42 and 23.89 ± 6.02 days for the proportion method in LJ medium, respectively, being statistically significant (p= 0.001). It was determined that the sensitivity test results of major antimycobacterial drugs in commercial LJ medium were compatible with the BACTEC 460 TB system. Nonetheless, the rate of incompatible results was higher for STR than the other drugs. Although there has been some disadvantages such as longer reporting time, need for experience in manual processing and visual evaluation, standardized LJ media approved for quality can be used for susceptibility testing of M.tuberculosis in the laboratories which do not have eligible conditions for the establishment of automated systems.
本研究旨在比较BACTEC 460 TB系统与比例法,用于在市售即用型添加抗生素的罗-琴(LJ)培养基中对结核分枝杆菌复合群分离株的一线药物进行药敏试验。本研究纳入了2006年至2010年期间从我们实验室临床样本中分离出的总共238株结核分枝杆菌菌株。按照制造商推荐的比例法,在市售LJ培养基(Salubris公司,伊斯坦布尔)中对链霉素、异烟肼、利福平和乙胺丁醇进行药敏试验,并将结果与BACTEC 460 TB(美国BD公司)系统的结果进行比较。通过BACTEC 460 TB系统获得的结核分枝杆菌菌株对链霉素、异烟肼、利福平和乙胺丁醇的耐药率分别为19.7%、42%、40.8%和18%。通过添加抗生素的LJ比例法获得的这些耐药率分别为22.7%、38.7%、37%和15.5%。两种方法在耐药率方面无统计学显著差异(p>0.05)。发现LJ培养基中的比例法与BACTEC 460 TB系统在链霉素、异烟肼、利福平和乙胺丁醇药敏试验方面的一致性率分别为85.3%、92.4%、95.4%和92.4%。在比较两种方法的报告时间(从过程开始到结果报告的间隔)时,BACTEC 460 TB系统的最短、最长和平均报告时长分别为5天、12天和8.08±2.65天,而LJ培养基中比例法的分别为15天、42天和23.89±6.02天,差异具有统计学意义(p=0.001)。已确定市售LJ培养基中主要抗分枝杆菌药物的药敏试验结果与BACTEC 460 TB系统相符。尽管如此,链霉素(STR)的结果不一致率高于其他药物。尽管存在报告时间较长、手工操作和视觉评估需要经验等一些缺点,但经质量批准的标准化LJ培养基可用于没有建立自动化系统合适条件的实验室中结核分枝杆菌的药敏试验。